A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys - Wikidata - awgldk - TriplyDB

A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys

A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys

http://www.wikidata.org/entity/Q33872457

about

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review Comparative primate genomics: emerging patterns of genome content and dynamics The population genomics of rhesus macaques (Macaca mulatta) based on whole-genome sequences In transition: primate genomics at a time of rapid change.μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.Large-scale polymorphism discovery in macaque G-protein coupled receptors.Expanding whole exome resequencing into non-human primates.Whole-genome characterization in pedigreed non-human primates using genotyping-by-sequencing (GBS) and imputation.Pharmacogenetic approaches to the treatment of alcohol addiction.Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression.Trace amine associated receptor 1 modulates behavioral effects of ethanol Opioid pharmacogenetics of alcohol addiction.The genetics of the opioid system and specific drug addictions Little evidence of a role for the α1GABAA subunit-containing receptor in a rhesus monkey model of alcohol drinking.Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.Convergent Balancing Selection on the Mu-Opioid Receptor in Primates.Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in Primates.

P2860

Q24616528-30C5B4EB-6645-4441-9D70-CA43A0160789 Q27006713-724A912F-0371-434A-9811-E6BB3C0881A2 Q28591103-C6EB7524-FE42-4CAE-BDF6-5090262C5DEE Q34381428-1B2FF8F7-966B-4E6E-BDE8-D06F0E66AF4C Q34975089-31B3D5B7-FF70-4682-B5CF-53036EACC1A3 Q34989821-475D2AD4-4D8C-4C71-96E8-31378C0181E7 Q35015836-1DBD5510-03C4-4887-B3C1-5A89717218D0 Q35840681-2D18AC33-4EE9-4410-B7FA-433AF39F878B Q36112251-142284F3-E49E-49B2-AF92-CA32AF3ECF88 Q36126591-A73984C7-EA82-42F4-8A30-162A8E4FF3C3 Q36150008-A01E7478-C44A-43B1-AB71-3DC14F281320 Q36874776-3D8BA6CC-66DA-4925-8319-6C29C0442412 Q36929548-7F69393D-662E-4C3A-AC09-4786DEE959FD Q36938466-32478C91-D114-4246-BBB9-CC8470E4DC6C Q37040492-1CF843C9-E5D4-4E16-919E-AA3173DF825B Q37698992-C06A0608-33A6-4680-BDB8-4DBF341B2572 Q38036386-7A4C0B92-21DC-41C7-8B2B-D250E737B453 Q38248763-1F660D13-C13A-4447-BCE2-651BC6755283 Q38638793-D03FC04D-FBFB-4E74-B874-53D47A3BA584 Q38741071-CFE49A59-74C9-44FA-8C68-3722B0515F9D Q42623009-DF88FE57-0926-49D3-AFF5-37F98CDACDE1

P2860

A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys

http://www.wikidata.org/entity/Q33872457

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@ast

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@en

type

label

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@ast

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@en

prefLabel

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@ast

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@en

P1433

Q33872457-5E1E6736-BE28-4C30-BE7F-754BEAB2800E

P1476

Q33872457-7CF96E6B-144B-44EA-ABF8-1C647F27DEBA

P2093

Q33872457-08ED4013-6DE4-4F57-BB98-C1D757C13377

Q33872457-46476C16-62C0-45E7-BA67-D543592E8135

Q33872457-7364E80F-48EE-48B8-A283-62CA1B0927CD

P2860

Q33872457-04A85BA2-63F7-4AE3-BD87-42D5DB741558

Q33872457-08DDFABA-A18D-4D0D-8E7E-B2E8B7C7CC4F

Q33872457-0A501672-3BE0-4BC8-8886-397F1842153F

Q33872457-151DFB8E-DCB3-41B1-B31A-012DB0DF80EC

Q33872457-2903B39B-0A00-4D36-87C9-6312353035F7

Q33872457-3AB15D0A-9434-4B46-80A5-8C30CD982F86

Q33872457-4D6AC49F-0003-4890-8387-AEF4C7F02B8D

Q33872457-6B133E09-C5A8-4714-AEAA-1C89C9E3B5DD

Q33872457-7164DB20-F99C-44F2-823A-79EA30E4AF30

Q33872457-7F5705A1-61F1-4C0E-9FBA-7B765B52D8DD

P304

Q33872457-793BC441-A809-4A8D-B13D-8F75C043A4B1

P31

Q33872457-DF0DD219-0ACC-45EB-9945-DAAAC4B63CE3

P356

Q33872457-87290F4E-A71E-482A-9FCE-848282712D62

P433

Q33872457-9204506D-0A97-47B2-B709-3E2AC716C08D

P478

Q33872457-D70B0200-78E0-4D8F-8051-CD773E1F7AF5

P50

Q33872457-3E3A5F72-5456-4065-A6CC-C8F818E08D24

P577

Q33872457-8DA6A92A-3169-4484-BE77-36D35108E594

P5875

Q33872457-FA7E55DD-BD72-4D42-95C7-EE8075B9C106

P698

Q33872457-35F8C8D4-1406-4D65-B46B-EF15F100B55C

P921

Q33872457-7E1DE67A-20DB-47FE-A36F-2DE748545F3F

Q33872457-E5771793-A663-4156-940F-B89E0561D4ED

P932

Q33872457-6B80CFAD-B15E-44E2-9C48-8706DC65869E

P356

J.DRUGALCDEP.2010.01.005

P1433

Drug and Alcohol Dependence

P1476

A pharmacogenetic model of nal ...... consumption in rhesus monkeys

@en

P2093

Daniela Rüedi-Bettschen

http://www.w3.org/2001/XMLSchema#string

Donna M Platt

http://www.w3.org/2001/XMLSchema#string

Gregory M Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.

Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.

Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque.

A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression.

Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals.

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

P304

252-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2010.01.005

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Eric J Vallender

P577

2010-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41428339

http://www.w3.org/2001/XMLSchema#string

P698

20153935

http://www.w3.org/2001/XMLSchema#string

P921

alcohol consumption

P932

2875311

http://www.w3.org/2001/XMLSchema#string